Out on Cancer TreatmentReviews
Advancements in #ColorectalCancer treatment:
Review of ongoing trials using liquid biopsy to detect circulating tumor DNA🧬 which could revolutionize adjuvant therapy decisions

✅Ongoing trials explore ctDNA-guided strategies, from de-escalation…

'Asha' means hope. FDA Oncology's Project Asha aims to increase oncology clinical trial access in India. India accounts for ~20% of the global population yet only 1.5% of global trials are conducted there. Lead: Geetika Srivastava MD MSPH
fda.gov/about-fda/onco…

#OCEProjectAsha

Manju George MVSc PhD Rectal Cancer Survivor OneOme We actually did a study 📚 with OneOme looking at feasibility of not just DPYD and UGT1A1, but also supportive care medications💊that are often used in patients with cancer.

#Pharmacogenomics #PGx #CRCSM

👇🏾This📝paper of ours can give you more insight.

journals.sagepub.com/doi/10.1177/15…

What r people's experience with OneOme pharmacogenomics testing? There's now a program through insurance & my 11yo got selected for it.
Though I ❤️ it as a scientific concept, trying to understand how exactly the test is done & what raw data is collected.
Any advice? #MedTwitter

It wasn’t pretty but officially a marathoner and what an incredible experience you gave Boston Marathon ColinsJoyProject 💙💛💙 🧡🤍💚 memories of a lifetime running with Amy Comander MD, DipABLM also from Mass General Cancer Center #BostonStrong #ColinStrong

When people bring you a problem, it's not always a sign that they blame you. It’s often a signal that they trust you.

Seeking support is an expression of vulnerability. It shows that they count on you to care and value your help.

It's a compliment to be chosen as a confidant.

If you’re someone who menstruates or previously menstruated and have been diagnosed with iron deficiency, what symptom was most bothersome to you?

Please retweet/share!

Knowing you were a victim is liberating. No longer blaming yourself for a bad circumstance empowers you to move forward.

Victimhood is limiting. Blaming others for all your suffering leaves you powerless to change your circumstances.

Pain is inevitable. Victimhood is a choice.

📣 Bernie Sanders is asking for input from #MedTwitter & #LongCovid patient/caregiver #advocacy community in advance of introducing a research funding bill for #LongCovid Moonshot. Read in full here & email to [email protected] by Tu 4/23/2024: sanders.senate.gov/wp-content/upl…

So happy to share my first Nature Nature Reviews Disease Primers publication, together with brilliant colleagues Garcia-Carbonero's Lab
Giuseppe Lamberti, Panzuto, Pavel, O’Toole, Ambrosini, Falconi, Rindi & Campana. on Gastric
#neuroendocrinecancer
go.nature.com/4aHikWE

NEW podcast out now!

Discover how to maximise outcomes with later-line treatment for your mCRC patients in this expert-led discussion

The full podcast is available on all platforms via this link ow.ly/L1G750RbEom

Click to listen NOW!

Victor Hugo Fonseca de Jesus #MedEd

This starry sky🌈🌌 is what the immune cells look like gathering around a cancer that’s getting killed.

What’s fascinating is the diversity and crosstalk. The focus on one type of cell is an oversimplification.

BOT diversifies➕BAL maintains.
#NEST -1 🪺trial

📸RareCyte, Inc. #CRCSM

Oncology Brothers Aparna Raj Parikh CancerNetwork® Santhosh Ambika Bijoy Telivala Yakup Ergün Dr. Cathy Eng Pamela Kunz, MD, FASCO Pashtoon Kasi MD, MS Myriam Chalabi Allison Rosen, MS Tanios Bekaii-Saab, MD Arvind Dasari, MD, MS Interesting that ctDNA positivity is making its way (slowly) into guidelines. Looking forward to radiographically occult MRD + studies that are starting to read out.

Fantastic lecture by Anant Madabhushi at #AACR24 - this slide shows the great need for more #pathologists across the world 🌎. AACR

Check out our scoping review of the field.. ripe for disruptive innovation

“Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancers”

If you are starting your lab, think about peritoneal metastases as an unmet scientific and therapeutic

Example of clinical workflow for AI usage (just one of many options) shared by Maryellen Giger at #AACR24
Note the bullets in red at the bottom and remember GIGO (garbage in / garbage out)
If we don't have representative data to feed algorithm, we are misusing AI #AACR2024

Lisa Newman, MD MPH Mary Beckerle AACR AdvocateCollaborative (ACE) NCCS - National Coalition for Cancer Survivorship ASCO OncoAlert 'Feedback sandwiches' ~ Dr. Bianca Islam, MD, PhD, MSc (she/her) sharing leading practices & knowledge nuggets around communicating with patients & advocates.
* Trust doesn't happen on the 1st visit
* Involve advocates in research
* Meet people where they are at
* it's not a one and done thing
#AACR24

GI Series: #ColonCancer algorithm, w/ Aparna Raj Parikh to reiterate the current landscape:

Full Discussion:
- cancernetwork.com/treatment-algo…
- Oncbrothers.com/colon-2024
-Also on the “Oncology Brothers” podcast

#OncTwitter CancerNetwork® #MedTwitter #GISM #crcsm

Screening for BRAFV600E for A022004 is free and easy. Can be done while patients are receiving adjuvant chemo. Let’s get going with screening and enrollment to this important trial!

⬇️ A primer on #ArtificialIntelligence for everyone involved in #CancerResearch to add to their “must read” list!

aacrjournals.org/cancerdiscover…

Cancer Discovery AACR Elizabeth McKenna Eli Van Allen #AACR24